{"database": "openregs", "table": "dockets", "rows": [["FDA-2005-E-0249", "FDA", "Patent Extension Application for Ovidrel (choriogonadotropin alfa (recombinant human chorionic gonadotripin (r-HCG)), U.S. Patent No. 4,840,896", "Nonrulemaking", "2021-09-01T01:01:21Z", "0b00006480444193"]], "columns": ["id", "agency_id", "title", "docket_type", "last_modified", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2005-E-0249"], "units": {}, "query_ms": 0.31458400189876556, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}